Hiroyu Hatano

5.8k total citations · 1 hit paper
39 papers, 3.5k citations indexed

About

Hiroyu Hatano is a scholar working on Virology, Infectious Diseases and Emergency Medicine. According to data from OpenAlex, Hiroyu Hatano has authored 39 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Virology, 30 papers in Infectious Diseases and 20 papers in Emergency Medicine. Recurrent topics in Hiroyu Hatano's work include HIV Research and Treatment (35 papers), HIV/AIDS Research and Interventions (25 papers) and HIV-related health complications and treatments (20 papers). Hiroyu Hatano is often cited by papers focused on HIV Research and Treatment (35 papers), HIV/AIDS Research and Interventions (25 papers) and HIV-related health complications and treatments (20 papers). Hiroyu Hatano collaborates with scholars based in United States, Sweden and Uganda. Hiroyu Hatano's co-authors include Peter W. Hunt, Steven G. Deeks, Jeffrey N. Martin, Joseph M. McCune, Elizabeth Sinclair, Michael P. Busch, Gilad Doitsh, Nicole Galloway, Kathryn M. Monroe and Zhiyuan Yang and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hiroyu Hatano

39 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection

2013 886 citations Gilad Doitsh, Nicole Galloway et al. Nature profile →

Peers

Countries citing papers authored by Hiroyu Hatano

Since Specialization

Citations

This map shows the geographic impact of Hiroyu Hatano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyu Hatano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyu Hatano more than expected).

Fields of papers citing papers by Hiroyu Hatano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyu Hatano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyu Hatano. The network helps show where Hiroyu Hatano may publish in the future.

Co-authorship network of co-authors of Hiroyu Hatano

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyu Hatano. A scholar is included among the top collaborators of Hiroyu Hatano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyu Hatano. Hiroyu Hatano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency 2018 ·PLoS Pathogens ·Sushama Telwatte, Sulggi A. Lee, Ma Somsouk, Hiroyu Hatano, Chris A. R. Baker, Philipp Kaiser, Peggy Kim, (unknown), Jeffrey M. Milush, (unknown), Steven G. Deeks, Joseph K. Wong, Steven A. Yukl	75
2	A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals 2017 ·SHILAP Revista de lepidopterología ·Leslie R. Cockerham, Steven A. Yukl, (unknown), Ma Somsouk, Sunil K. Joshi, Elizabeth Sinclair, Teri Liegler, Rebecca Hoh, (unknown), Peter W. Hunt, Adam Rupert, Irini Sereti, David R. Morcock, Ajantha Rhodes, Claire Emson, Marc K. Hellerstein, Jacob D. Estes, Sharon R. Lewin, Steven G. Deeks, Hiroyu Hatano	9
3	Post-Treatment Controllers: Role in HIV “Cure” Research 2016 ·Current HIV/AIDS Reports ·Leslie R. Cockerham, Hiroyu Hatano, Steven G. Deeks	23
4	Immunologic profiles distinguish aviremic HIV-infected adults 2016 ·AIDS ·Christina M. Ramirez, Elizabeth Sinclair, Lorrie Epling, Sulggi A. Lee, Vivek Jain, Priscilla Y. Hsue, Hiroyu Hatano, (unknown), Frederick Hecht, Jeffrey N. Martin, Joseph M. McCune, Steven G. Deeks, Peter W. Hunt	15
5	Programmed death-1 expression on CD4+ and CD8+ T cells in treated and untreated HIV disease 2014 ·AIDS ·Leslie R. Cockerham, Vivek Jain, Elizabeth Sinclair, David V. Glidden, (unknown), Hiroyu Hatano, Peter W. Hunt, Jeffrey N. Martin, Christopher D. Pilcher, Rafick‐Pierre Sékaly, Joseph M. McCune, Frederick Hecht, Steven G. Deeks	95
6	Lymphoid Fibrosis Occurs in Long-Term Nonprogressors and Persists With Antiretroviral Therapy but May Be Reversible With Curative Interventions 2014 ·The Journal of Infectious Diseases ·(unknown), Peter W. Hunt, Cavan Reilly, Hiroyu Hatano, Gregory J. Beilman, Alexander Khoruts, (unknown), Ma Somsouk, Ann Thorkelson, (unknown), Jodi Anderson, Steven G. Deeks, Timothy W. Schacker	49
7	Impact of HIV on CD8+ T Cell CD57 Expression Is Distinct from That of CMV and Aging 2014 ·PLoS ONE ·Sulggi A. Lee, Elizabeth Sinclair, Hiroyu Hatano, Priscilla Y. Hsue, Lorrie Epling, Frederick Hecht, David R. Bangsberg, Jeffrey N. Martin, Joseph M. McCune, Steven G. Deeks, Peter W. Hunt	80
8	Reduction of HIV Persistence Following Transplantation in HIV-Infected Kidney Transplant Recipients 2014 ·American Journal of Transplantation ·Peter G. Stock, Burc Barin, Hiroyu Hatano, (unknown), Michelle E. Roland, (unknown), Michael P. Busch, Steven G. Deeks	53
9	Elite control of HIV: is this the right model for a functional cure? 2014 ·Trends in Microbiology ·Leslie R. Cockerham, Hiroyu Hatano	19
10	A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells, including myeloid cells 2013 ·AIDS ·Steven A. Yukl, Elizabeth Sinclair, Ma Somsouk, Peter W. Hunt, Lorrie Epling, Maudi Killian, Valerie Girling, Peilin Li, Diane V. Havlir, Steven G. Deeks, Joseph K. Wong, Hiroyu Hatano	52
11	Antiretroviral Therapy Initiated Within 6 Months of HIV Infection Is Associated With Lower T-Cell Activation and Smaller HIV Reservoir Size 2013 ·The Journal of Infectious Diseases ·Vivek Jain, Wendy Hartogensis, Peter Bacchetti, Peter W. Hunt, Hiroyu Hatano, Elizabeth Sinclair, Lorrie Epling, Tzong‐Hae Lee, Michael P. Busch, Joseph M. McCune, Christopher D. Pilcher, Frederick Hecht, Steven G. Deeks	230
12	Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection breakdown → 2013 ·Nature ·Gilad Doitsh, Nicole Galloway, Xin Geng, Zhiyuan Yang, Kathryn M. Monroe, (unknown), Peter W. Hunt, Hiroyu Hatano, Stefanie Sowinski, (unknown), Warner C. Greene	886
13	Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers 2013 ·AIDS ·Hiroyu Hatano, Ma Somsouk, Elizabeth Sinclair, (unknown), (unknown), Michelle Cohen, Rebecca Hoh, Peter W. Hunt, Jeffrey N. Martin, Joseph K. Wong, Steven G. Deeks, Steven A. Yukl	39
14	Cell-Based Measures of Viral Persistence Are Associated With Immune Activation and Programmed Cell Death Protein 1 (PD-1)–Expressing CD4+ T cells 2012 ·The Journal of Infectious Diseases ·Hiroyu Hatano, Vivek Jain, Peter W. Hunt, Tzong‐Hae Lee, Elizabeth Sinclair, (unknown), Rebecca Hoh, Jeffrey N. Martin, Joseph M. McCune, Frederick Hecht, Michael P. Busch, Steven G. Deeks	195
15	A Randomized Controlled Trial Assessing the Effects of Raltegravir Intensification on Endothelial Function in Treated HIV Infection 2012 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Hiroyu Hatano, Rebecca Scherzer, Yuaner Wu, (unknown), (unknown), Rebecca Hoh, Elizabeth Sinclair, Sarah Palmer, Jeffrey N. Martin, Michael P. Busch, Steven G. Deeks, Priscilla Y. Hsue	33
16	Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes 2010 ·Journal of Virological Methods ·Peilin Li, Theodore Ruel, Katsuya Fujimoto, Hiroyu Hatano, Steven A. Yukl, Leigh Anne Eller, Teri Liegler, Moses R. Kamya, (unknown), Grant Dorsey, Philip Rosenthal, Diane V. Havlir, Joseph K. Wong	15
17	Evolution of Integrase Resistance During Failure of Integrase Inhibitor-Based Antiretroviral Therapy 2010 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Hiroyu Hatano, Harry Lampiris, Signe Fransen, Soumi Gupta, Wei Huang, Rebecca Hoh, Jeffrey N. Martin, Jacob Lalezari, David R. Bangsberg, Christos J. Petropoulos, Steven G. Deeks	62
18	Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals 2010 ·AIDS ·Hiroyu Hatano, Eric Delwart, Philip J. Norris, Tzong‐Hae Lee, Torsten B. Neilands, Colleen F. Kelley, Peter W. Hunt, Rebecca Hoh, Jeffrey M. Linnen, Jeffrey N. Martin, Michael P. Busch, Steven G. Deeks	58
19	Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients 2009 ·AIDS ·Priscilla Y. Hsue, Peter W. Hunt, Yuaner Wu, Amanda Schnell, Jennifer E. Ho, Hiroyu Hatano, Yu Xie, Jeffrey N. Martin, Peter Ganz, Steven G. Deeks	128
20	HLA Class I-Restricted T-Cell Responses May Contribute to the Control of Human Immunodeficiency Virus Infection, but Such Responses Are Not Always Necessary for Long-Term Virus Control 2008 ·Journal of Virology ·Brinda Emu, Elizabeth Sinclair, Hiroyu Hatano, April L. Ferre, Barbara L. Shacklett, Jeffrey N. Martin, Joseph M. McCune, Steven G. Deeks	174

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact